Target Name: H2BC7
NCBI ID: G8343
Review Report on H2BC7 Target / Biomarker Content of Review Report on H2BC7 Target / Biomarker
H2BC7
Other Name(s): H2B histone family, member G | Histone H2B type 1-C/E/F/G/I | Histone H2B.h | H2B/h | histone H2B.g | H2BFG | H2B1C_HUMAN | H2BC10 | histone cluster 1, H2bf | H2BC8 | histone H2B.1 A | H2B/l | H2B/a | H2B/k | HIST1H2BF | Histone H2B.1 A | H2BC4 | Histone H2B.a | histone 1, H2bf | H2BC6 | histone cluster 1 H2B family member f | Histone H2B.g | H2B/g | H2B clustered histone 7 | H2B/i | Histone H2B.l | Histone H2B.k

H2B.G: A Potential Drug Target for Age-Related Diseases

The H2B histone family plays a critical role in the regulation of gene expression and cell behavior. One of its members, H2B.G, is a protein that is often targeted by drugs as a potential drug target or biomarker.

The H2B histone family consists of several proteins that share a common core domain and a unique N-terminus. The core domain consists of a specific sequence that is often involved in the formation of a nucleosome, a basic unit of chromatin. The N-terminus of each member of the family contains a unique variant that is involved in the interaction with co-chaperones and other proteins.

H2B.G is a 21-kDa protein that is expressed in a variety of tissues, including brain, heart, and muscle. It is highly homogeneous with a calculated pI of 9.67. H2B.G is a monomer and has a linear molecular weight of 119 kDa.

H2B.G has been shown to play a role in the regulation of gene expression and cell behavior. One of its well-documented functions is its role in the regulation of the expression of the gene involved in the development and maintenance of axon guidance in the nervous system.

H2B.G has also been shown to play a role in the regulation of cell adhesion and migration. It has been shown to be involved in the regulation of tight junction formation and the migration of neurons in the brain.

In addition to its role in gene regulation, H2B.G has also been shown to play a role in the regulation of protein stability. It has been shown to play a role in the regulation of the stability and localization of the protein involved in the regulation of microtubule dynamics.

Given its unique structure and its involvement in several critical processes, H2B.G is an attractive target for drug development. Studies have shown that H2B.G can be inhibited by small molecules, including inhibitors of the tyrosine kinase activity of H2B.G. In addition, H2B.G has been shown to be involved in several cellular processes that are associated with aging and neurodegeneration. Therefore, it is a potential drug target that could have significant implications for the treatment of age-related diseases.

In conclusion, H2B.G is a protein that has been shown to play a critical role in the regulation of gene expression and cell behavior. Its unique structure and its involvement in several critical processes make it an attractive target for drug development. Further studies are needed to fully understand the implications of H2B.G as a drug target and to develop effective treatments for age-related diseases.

Protein Name: H2B Clustered Histone 7

Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling

The "H2BC7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H2BC7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3 | HAUS4 | HAUS5 | HAUS6 | HAUS7 | HAUS8